EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation

PLoS Pathogens

Volumn 12, Issue 8, 2016, Pages

  Pei, Yonggang ^a   Banerjee, Shuvomoy ^a   Sun, Zhiguo ^a   Jha, Hem Chandra ^a   Saha, Abhik ^b   Robertson, Erle S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PRESIDENCY UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 3C; MESSENGER RNA; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F6; UNCLASSIFIED DRUG; VIRUS ANTIGEN; E2F1 PROTEIN, HUMAN; E2F6 PROTEIN, HUMAN; EPSTEIN BARR VIRUS ANTIGEN;

ARTICLE; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA TRANSCRIPTION; EPSTEIN BARR VIRUS; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LUCIFERASE ASSAY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

CELL PROLIFERATION; E2F1 TRANSCRIPTION FACTOR; E2F6 TRANSCRIPTION FACTOR; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; TRANSCRIPTION, GENETIC;

EID: 84984788469     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005844     Document Type: Article

References (60)

1. Johannsen E, Miller CL, Grossman SR, Kieff E, (1996) EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes. J Virol70: 4179–4183. 8648764
2. Lin J, Johannsen E, Robertson E, Kieff E, (2002) Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2. J Virol76: 232–242. 11739688
3. Libermann TA, Zerbini LF, (2006) Targeting transcription factors for cancer gene therapy. Curr Gene Ther6: 17–33. 16475943
4. Yi F, Saha A, Murakami M, Kumar P, Knight JS, et al. (2009) Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. Virology388: 236–247. doi: 10.1016/j.virol.2009.03.02719394062
5. Banerjee S, Lu J, Cai Q, Saha A, Jha HC, et al. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8. PLoS Pathog9: e1003314. doi: 10.1371/journal.ppat.100331423658517
6. Saha A, Lu J, Morizur L, Upadhyay SK, Aj MP, et al. E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells. PLoS Pathog8: e1002573. doi: 10.1371/journal.ppat.100257322438805
7. Giangrande PH, Zhu W, Schlisio S, Sun X, Mori S, et al. (2004) A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription. Genes Dev18: 2941–2951. 15574595
8. Gaubatz S, Wood JG, Livingston DM, (1998) Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc Natl Acad Sci U S A95: 9190–9195. 9689056
9. Trimarchi JM, Fairchild B, Verona R, Moberg K, Andon N, et al. (1998) E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc Natl Acad Sci U S A95: 2850–2855. 9501179
10. Yang WW, Shu B, Zhu Y, Yang HT, (2008) E2F6 inhibits cobalt chloride-mimetic hypoxia-induced apoptosis through E2F1. Mol Biol Cell19: 3691–3700. doi: 10.1091/mbc.E08-02-017118562691
11. Kikuchi J, Shimizu R, Wada T, Ando H, Nakamura M, et al. (2007) E2F-6 suppresses growth-associated apoptosis of human hematopoietic progenitor cells by counteracting proapoptotic activity of E2F-1. Stem Cells25: 2439–2447. 17600109
12. Cartwright P, Muller H, Wagener C, Holm K, Helin K, (1998) E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene17: 611–623. 9704927
13. Saha A, Robertson ES, Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis. Future Microbiol8: 323–352. doi: 10.2217/fmb.12.14723464371
14. Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S, et al. (2009) Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim Biophys Sin (Shanghai)41: 414–428.
15. Attwooll C, Lazzerini Denchi E, Helin K, (2004) The E2F family: specific functions and overlapping interests. EMBO J23: 4709–4716. 15538380
16. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR, (1997) Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A94: 7245–7250. 9207076
17. Tsai SY, Opavsky R, Sharma N, Wu L, Naidu S, et al. (2008) Mouse development with a single E2F activator. Nature454: 1137–1141. doi: 10.1038/nature0706618594513
18. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, et al. (2001) The E2F1-3 transcription factors are essential for cellular proliferation. Nature414: 457–462. 11719808
19. Chen HZ, Tsai SY, Leone G, (2009) Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer9: 785–797. doi: 10.1038/nrc269619851314
20. Muller H, Moroni MC, Vigo E, Petersen BO, Bartek J, et al. (1997) Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol Cell Biol17: 5508–5520. 9271426
21. Morkel M, Wenkel J, Bannister AJ, Kouzarides T, Hagemeier C, (1997) An E2F-like repressor of transcription. Nature390: 567–568. 9403682
22. Polager S, Ginsberg D, (2009) p53 and E2f: partners in life and death. Nat Rev Cancer9: 738–748. doi: 10.1038/nrc271819776743
23. Ankers JM, Awais R, Jones NA, Boyd J, Ryan S, et al. (2016) Dynamic NF-kappaB and E2F interactions control the priority and timing of inflammatory signalling and cell proliferation. Elife5.
24. Burkhart DL, Sage J, (2008) Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer8: 671–682. doi: 10.1038/nrc239918650841
25. Dimova DK, Dyson NJ, (2005) The E2F transcriptional network: old acquaintances with new faces. Oncogene24: 2810–2826. 15838517
26. Nevins JR, (2001) The Rb/E2F pathway and cancer. Hum Mol Genet10: 699–703. 11257102
27. Saha A, Lu J, Morizur L, Upadhyay SK, Aj MP, et al. (2012) E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells. PLoS Pathog8: e1002573. doi: 10.1371/journal.ppat.100257322438805
28. Cai Q, Guo Y, Xiao B, Banerjee S, Saha A, et al. Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis. PLoS Pathog7: e1002418. doi: 10.1371/journal.ppat.100241822174681
29. Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, et al. Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1. PLoS Pathog7: e1001275. doi: 10.1371/journal.ppat.100127521347341
30. Swenson JJ, Mauser AE, Kaufmann WK, Kenney SC, (1999) The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. J Virol73: 6540–6550. 10400750
31. Everly DN, Jr.Mainou BA, Raab-Traub N, (2009) Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation. J Virol83: 12671–12679. doi: 10.1128/JVI.01422-0919828622
32. Ohtani N, Brennan P, Gaubatz S, Sanij E, Hertzog P, et al. (2003) Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5. J Cell Biol162: 173–183. 12860972
33. Trimarchi JM, Fairchild B, Wen J, Lees JA, (2001) The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc Natl Acad Sci U S A98: 1519–1524. 11171983
34. Schlisio S, Halperin T, Vidal M, Nevins JR, (2002) Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function. EMBO J21: 5775–5786. 12411495
35. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, et al. (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science298: 1039–1043. 12351676
36. Min J, Zhang Y, Xu RM, (2003) Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27. Genes Dev17: 1823–1828. 12897052
37. Wu CY, Kang HY, Yang WL, Wu J, Jeong YS, et al. (2011) Critical role of monoubiquitination of histone H2AX protein in histone H2AX phosphorylation and DNA damage response. J Biol Chem286: 30806–30815. doi: 10.1074/jbc.M111.25746921690091
38. Tavares L, Dimitrova E, Oxley D, Webster J, Poot R, et al. (2012) RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3. Cell148: 664–678. doi: 10.1016/j.cell.2011.12.02922325148
39. Mesri EA, Feitelson MA, Munger K, (2014) Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe15: 266–282. doi: 10.1016/j.chom.2014.02.01124629334
40. West MJ, (2006) Structure and function of the Epstein-Barr virus transcription factor, EBNA 3C. Curr Protein Pept Sci7: 123–136. 16611138
41. Tomkinson B, Robertson E, Kieff E, (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol67: 2014–2025. 8445720
42. Bajaj BG, Murakami M, Cai Q, Verma SC, Lan K, et al. (2008) Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein. J Virol82: 4082–4090. doi: 10.1128/JVI.02500-0718256156
43. Rosendorff A, Illanes D, David G, Lin J, Kieff E, et al. (2004) EBNA3C coactivation with EBNA2 requires a SUMO homology domain. J Virol78: 367–377. 14671118
44. Knight JS, Lan K, Subramanian C, Robertson ES, (2003) Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. J Virol77: 4261–4272. 12634383
45. Touitou R, Hickabottom M, Parker G, Crook T, Allday MJ, (2001) Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C. J Virol75: 7749–7755. 11462050
46. Yan X, Mouillet JF, Ou Q, Sadovsky Y, (2003) A novel domain within the DEAD-box protein DP103 is essential for transcriptional repression and helicase activity. Mol Cell Biol23: 414–423. 12482992
47. Subramanian C, Hasan S, Rowe M, Hottiger M, Orre R, et al. (2002) Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation. J Virol76: 4699–4708. 11967287
48. Subramanian C, Cotter MA, 2ndRobertson ES, (2001) Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat Med7: 350–355. 11231635
49. Saha A, Murakami M, Kumar P, Bajaj B, Sims K, et al. (2009) Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2. J Virol83: 4652–4669. doi: 10.1128/JVI.02408-0819244339
50. Saha A, Bamidele A, Murakami M, Robertson ES, EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5. J Virol85: 2079–2088. doi: 10.1128/JVI.02279-1021177815
51. Zhou H, Schmidt SC, Jiang S, Willox B, Bernhardt K, et al. (2015) Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microbe17: 205–216. doi: 10.1016/j.chom.2014.12.01325639793
52. Halder S, Murakami M, Verma SC, Kumar P, Yi F, et al. (2009) Early events associated with infection of Epstein-Barr virus infection of primary B-cells. PLoS One4: e7214. doi: 10.1371/journal.pone.000721419784370
53. Banerjee S, Lu J, Cai Q, Saha A, Jha HC, et al. (2013) The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8. PLoS Pathog9: e1003314. doi: 10.1371/journal.ppat.100331423658517
54. Johnson DG, Ohtani K, Nevins JR, (1994) Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev8: 1514–1525. 7958836
55. Jha HC, A JM Saha A, Banerjee S, Lu J, et al. (2014) Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression. J Virol88: 3776–3788. doi: 10.1128/JVI.03568-1324429368
56. Maunders MJ, Petti L, Rowe M, (1994) Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody. J Gen Virol75 (Pt 4): 769–778. 7512118
57. Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, et al. (1995) Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. J Virol69: 3108–3116. 7707539
58. Cotter MA, 2ndRobertson ES, (2000) Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha. Mol Cell Biol20: 5722–5735. 10891508
59. Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, et al. (2011) Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1. PLoS Pathog7: e1001275. doi: 10.1371/journal.ppat.100127521347341
60. Lu J, Murakami M, Verma SC, Cai Q, Haldar S, et al. (2011) Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology410: 64–75. doi: 10.1016/j.virol.2010.10.02921093004